Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate in Cocaine Dependent Patients With Adult ADHD
NCT00015223Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Jun 1997
- Primary completion
- Jul 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methylphenidate in cocaine dependence and attention deficit hyperactivity disorder (ADHD), sponsored by National Institute on Drug Abuse. Primary endpoints: Cocaine use at 10 weeks, Methylphenidate retention at 10 weeks and 2 more. Started Jun 1997; status: completed.
02
Drugs
methylphenidate
03
Conditions
cocaine dependenceattention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00015223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00015223.